ACER THERAPEUTICS INC's ticker is and the CUSIP is 00444P908. A total of 3 filers reported holding ACER THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2,510 | -68.6% | 1,000 | -81.5% | 0.00% | – |
| Q3 2022 | $8,000 | -74.2% | 5,400 | -78.1% | 0.00% | – |
| Q2 2022 | $31,000 | +3000.0% | 24,700 | +12250.0% | 0.00% | – |
| Q1 2022 | $1,000 | -80.0% | 200 | -90.5% | 0.00% | – |
| Q4 2021 | $5,000 | 0.0% | 2,100 | +5.0% | 0.00% | – |
| Q3 2021 | $5,000 | -86.8% | 2,000 | -85.0% | 0.00% | – |
| Q2 2021 | $38,000 | -13.6% | 13,300 | -7.0% | 0.00% | – |
| Q1 2021 | $44,000 | – | 14,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |